Saltar al contenido
Merck

Cellulose triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration.

Blood purification (2010-05-21)
Shuangxin Liu, Wei Shi, Xinling Liang, Yong Su, Yongzhen Liang, Bin Zhang, Zhiming Ye, Lixia Xu, Yunfeng Xia, Chaoshen He, Jianchao Ma, Yiming Tao, Hen Ye, Hui Li
RESUMEN

Thrombocytopenia is a common complication in patients receiving continuous veno-venous hemofiltration (CVVH) in the intensive care unit. The hemofilter itself plays an important role in the genesis of thrombocytopenia. The present study was undertaken to test whether there were differences in platelet loss and activation during CVVH with a polysulfone (PS) hemofilter or a cellulose triacetate (CTA) dialyzer. 96 patients with thrombocytopenia and acute kidney injury requiring CVVH were randomly assigned to four groups receiving low-molecular-weight heparin (LMWH) PS (n = 24), LMWH CTA (n = 24), no anticoagulation PS (n = 24), and no anticoagulation CTA (n = 24), respectively. We found a significant decrease in platelet counts, but an increased platelet activation with the PS hemofilter in patients who received no anticoagulation. There was no significant decrease in platelet counts and activation in the CTA group. The cellulose membranes could be an effective alternative to the standard synthetic membranes in patients at high risk for thrombocytopenia during CVVH.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Cellulose triacetate, Selectophore